Arcus Biosciences (RCUS) Other Operating Expenses (2020 - 2024)
Arcus Biosciences (RCUS) recorded quarterly Other Operating Expenses of $20.0 million in Q1 2024, up 8164.52% quarter-over-quarter from -$248000.0 in Q4 2020.
Arcus Biosciences (RCUS) Other Operating Expenses (2020 - 2024) Analysis & Trends
Arcus Biosciences' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $20.0 million for Q1 2024.
- In Q1 2024, Other Operating Expenses changed N/A year-over-year to $20.0 million; the TTM figure through Dec 2024 stood at $20.0 million (changed N/A YoY), while the FY2024 annual figure was $20.0 million, changed N/A from the prior year.
- Other Operating Expenses was $20.0 million for Q1 2024 at Arcus Biosciences, up from -$248000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $20.0 million in Q1 2024 to a low of -$248000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcus Biosciences | 3.05 Bn | 2.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 20.00 Mn |
| Dec 31, 2020 | -248,000.00 |